Funding for this research was provided by:
National Institutes of Health (HL108016, CA148572)
George Isaac Cancer Research Fund
Received: 8 November 2017
Accepted: 23 February 2018
First Online: 5 March 2018
Ethics approval and consent to participate
: Collection and use of samples and corresponding medical/demographic data was approved under University of Toledo IRB protocols #108538 and #107844. Each subject included in this study provided written informed consent.
: Not applicable.
: JCW is a consultant for and has equity interest in Accugenomics, Inc. which has a financial interest in the data presented here. JCW, TB and ELC have issued and pending patents for the technology and biomarkers presented here. Other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.